Raloxifene

Source:http://linkedlifedata.com/resource/umls/id/C0244404

CSP: a selective estrogen receptor modulator; has both agonist and antagonist estrogen action.,NCI: The active ingredient in a drug used to reduce the risk of invasive breast cancer in postmenopausal women who are at high risk of the disease or who have osteoporosis. It is also used to prevent and treat osteoporosis in postmenopausal women. It is also being studied in the prevention of breast cancer in certain premenopausal women and in the prevention and treatment of other conditions. Raloxifene blocks the effects of the hormone estrogen in the breast and increases the amount of calcium in bone. It is a type of selective estrogen receptor modulator (SERM).,MSH: A second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue.,PDQ: A selective benzothiophene estrogen receptor modulator (SERM). Raloxifene binds

Download in:

View as